Aslan Pharmaceuticals

Aslan Pharmaceuticals is a company listed under the stock ticker ASLN.O (SG).

View the org chart displaying its 9 main executives

Most searched biographies at Aslan Pharmaceuticals

• Carl Firth, Chief Executive Officer and Director
• Andrew Howden, Chairman of the Board
• Neil Graham, Director

Create your alert
to follow the executive moves at Aslan Pharmaceuticals.

Aslan Pharmaceuticals has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Aslan Pharmaceuticals

• News & Publications - ASLAN Pharmaceuticals
• News & Publications - ASLAN Pharmaceuticals
• News & Publications - ASLAN Pharmaceuticals
• News & Publications - ASLAN Pharmaceuticals

Social media about Aslan Pharmaceuticals

• Aslan Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Aslan Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Carl Firth

Call Aslan Pharmaceuticals at +65 65...

View the org chart

Register to receive your alert

Report an error